Overview

Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers

Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of single subcutaneous injection of Genakumab for Injection in Chinese healthy adult volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GeneScience Pharmaceuticals Co., Ltd.
Collaborator:
Peking Union Medical College Hospital